-
IntroducedJan 29, 2025
-
Passed Senate
-
Passed House
-
Signed into Law
TO MANDATE THE USE OF BIOSIMILAR MEDICINES UNDER HEALTH BENEFIT PLANS; TO REQUIRE A HEALTHCARE PROVIDER TO PRESCRIBE BIOSIMILAR MEDICINES; AND TO IMPROVE ACCESS TO BIOSIMILAR MEDICINES.
Last Action See all actions
Senate • Apr 01, 2025: Recommended for study in the Interim Committee on INSURANCE & COMMERCE - SENATE
Latest Bill Text See all bill texts
Summary/Bill Text
Comments on SB 140
Tweets
Whip Lists
Sponsors
Votes
Actions
- Apr 01, 2025 | Senate
- Withdrawn from Committee and placed on calendar.
- Recommended for study in the Interim Committee on INSURANCE & COMMERCE - SENATE
- Mar 10, 2025 | Senate
- Withdrawn from Committee and placed on 2nd reading for purpose of amendment # 2
- Amendment # 2 read the first time, rules suspended, read the second time and adopted, ordered engrossed.
- REPORTED CORRECTLY ENGROSSED
- Re-referred to INSURANCE & COMMERCE - SENATE
- Feb 05, 2025 | Senate
- Withdrawn from Committee and placed on 2nd reading for purpose of amendment # 1
- Amendment # 1 read the first time, rules suspended, read the second time and adopted, ordered engrossed.
- REPORTED CORRECTLY ENGROSSED
- Re-referred to INSURANCE & COMMERCE - SENATE
- Jan 29, 2025 | Senate
- Filed
- Read first time, rules suspended, read second time, referred to INSURANCE & COMMERCE - SENATE